<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd">
<collection>
	<source>PubMed</source>
	<date>May 04, 2015</date>
	<key>rlims_bioc.key</key>
	<document>
		<id>0000</id>
		<passage>
			<offset>0</offset>
			<text>PMID - 0000TI - Title not provided .AB - Malignant mesothelioma
				( MM ) is an aggressive neoplasm causatively associated with
				exposure to asbestos .MM is rarely responsive to conventional
				cytotoxic drugs , and the outcome remains dismal .It is , therefore
				, necessary to identify the signaling pathways that drive MM and to
				develop new therapeutics specifically targeting the molecules
				involved .We performed comprehensive RNA sequencing of 12 MM cell
				lines and four clinical samples using so-called next-generation
				sequencers .We found 15 novel fusion transcripts including one
				derived from chromosomal translocation between the large tumor
				suppressor 1 ( LATS1 ) and presenilin-1 ( PSEN1 ) genes .LATS1 is
				one of the central players of the emerging Hippo signaling pathway
				.The LATS1-PSEN1 fusion gene product lacked the ability to
				phosphorylate yes-associated protein and to suppress the growth of a
				MM cell line .The wild-type LATS1 allele was undetectable in this
				cell line , indicating two-hit genetic inactivation of its tumor
				suppressor function .Using pathway-targeted exon sequencing , we
				further identified a total of 11 somatic mutations in four Hippo
				pathway genes ( neurofibromatosis type 2 [NF2] , LATS2 , RASSF1 ,
				and SAV1 ) in 35% ( 8 of 23 ) of clinical samples .Nuclear staining
				of yes-associated protein was detected in 55% ( 24 of 44 ) of the
				clinical samples .Expression and/or phosphorylation of the Hippo
				signaling proteins , RASSF1 , Merlin (NF2) , LATS1 , and LATS2 , was
				frequently absent .The frequent alterations of Hippo pathway
				molecules found in this study indicate the therapeutic feasibility
				of targeting this pathway in patients with MM .</text>
			<annotation id="t1">
				<infon key="rlims_internal_representation">phosphorylation</infon>
				<location offset="1393" length="33" />
				<text>Expression and/or phosphorylation</text>
			</annotation>
			<annotation id="t2">
				<infon key="rlims_internal_representation">LATS1</infon>
				<location offset="1461" length="41" />
				<text>RASSF1 , Merlin (NF2) , LATS1 , and LATS2</text>
			</annotation>
			<relation id="r0">
				<infon key="PTM_type">phosphorylation</infon>
				<node refid="t1" role="trigger" />
				<node refid="t2" role="substrate" />
			</relation>
			<relation id="r1">
				<infon key="PTM_type">phosphorylation</infon>
				<node refid="t1" role="trigger" />
				<node refid="t2" role="substrate" />
			</relation>
			<relation id="r2">
				<infon key="PTM_type">phosphorylation</infon>
				<node refid="t1" role="trigger" />
				<node refid="t2" role="substrate" />
			</relation>
			<relation id="r3">
				<infon key="PTM_type">phosphorylation</infon>
				<node refid="t1" role="trigger" />
				<node refid="t2" role="substrate" />
			</relation>
		</passage>
	</document>
</collection>